Nordic Capital acquisition of The Binding Site may propel strategic expansion
This article was originally published in Scrip
Executive Summary
Private equity firm Nordic Capital has acquired UK immunodiagnostics specialist The Binding Site for an undisclosed fee, and is likely to overhaul the company operationally in order to maximise the market opportunity for its cancer diagnostic products.